US Stock MarketDetailed Quotes

ICCM Icecure Medical

Watchlist

0.658
-0.005-0.77%

Close Aug 2 16:00 ET

0.660
+0.002+0.30%

Post 20:01 ET

31.54MMarket Cap-2055P/E (TTM)

Icecure Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

2.89%-2.85M

12.39%-12.52M

35.95%-2.64M

0.06%-3.32M

4.28%-3.62M

4.02%-2.94M

-13.38%-14.29M

29.96%-4.13M

-5.37%-3.32M

-120.31%-3.79M

Net income from continuing operations

4.22%-3.61M

13.70%-14.65M

24.22%-3M

1.43%-4M

13.98%-3.89M

15.27%-3.77M

-71.58%-16.98M

-25.06%-3.95M

-40.51%-4.06M

-82.59%-4.52M

Operating gains losses

437.50%43K

-106.96%-25K

-93.22%-228K

223.53%105K

-82.00%90K

-87.10%8K

7,080.00%359K

-71.01%-118K

-269.57%-85K

558.72%500K

Depreciation and amortization

7.59%85K

30.24%323K

12.16%83K

17.14%82K

51.92%79K

95.28%248K

80.49%74K

94.44%70K

92.59%52K

Change In working capital

-1.03%384K

144.39%523K

129.97%193K

-43.01%163K

11.95%-221K

-52.86%388K

106.78%214K

76.73%-644K

182.90%286K

-133.33%-251K

-Change in receivables

16.92%-54K

-106.61%-25K

-95.76%5K

183.33%10K

-90.46%25K

-750.00%-65K

204.42%378K

131.98%118K

-271.43%-12K

67.95%262K

-Change in inventory

330.99%164K

164.52%582K

333.33%371K

323.40%105K

154.13%177K

80.76%-71K

-1.23%-902K

12.15%-159K

84.79%-47K

-23.86%-327K

-Change in prepaid assets

-86.10%52K

-52.76%496K

125.04%161K

-177.83%-316K

-50.45%277K

-48.63%374K

151.72%1.05M

64.20%-643K

409.92%406K

9,216.67%559K

-Change in payables and accrued expense

637.93%156K

-26.95%-212K

-659.82%-627K

242.39%477K

-112.36%-33K

86.26%-29K

-170.76%-167K

166.67%112K

-1,057.14%-335K

92.09%267K

-Change in other current assets

56.25%75K

-25.71%182K

-21.95%64K

-17.65%56K

-78.79%14K

65.52%48K

140.36%245K

-29.31%82K

109.16%68K

375.00%66K

-Change in other current liabilities

-106.87%-9K

-28.21%-500K

242.21%219K

-182.04%-169K

36.83%-681K

-79.40%131K

-178.63%-390K

73.45%-154K

-74.09%206K

-245.68%-1.08M

Cash from discontinued investing activities

Operating cash flow

2.89%-2.85M

12.39%-12.52M

35.95%-2.64M

0.06%-3.32M

4.28%-3.62M

4.02%-2.94M

-13.38%-14.29M

29.96%-4.13M

-5.37%-3.32M

-120.31%-3.79M

Investing cash flow

Cash flow from continuing investing activities

103.25%491K

19.98%-713K

440.27%9.06M

90.74%4.2M

124.86%1.15M

-10,400.00%-15.12M

-123.50%-891K

1,036.31%1.68M

2,139.81%2.2M

-878.01%-4.63M

Net PPE purchase and sale

88.80%-28K

46.13%-480K

19.00%-81K

74.16%-77K

79.37%-72K

-73.61%-250K

-67.17%-891K

43.82%-100K

-175.93%-298K

-96.07%-349K

Net investment purchase and sale

103.56%529K

---529K

397.75%8.84M

71.09%4.28M

128.57%1.22M

---14.87M

--0

502.03%1.78M

--2.5M

-1,349.83%-4.28M

Net other investing changes

---10K

--296K

----

Cash from discontinued investing activities

Investing cash flow

103.25%491K

19.98%-713K

440.27%9.06M

90.74%4.2M

124.86%1.15M

-10,400.00%-15.12M

-123.50%-891K

1,036.31%1.68M

2,139.81%2.2M

-878.01%-4.63M

Financing cash flow

Cash flow from continuing financing activities

2.84M

-99.39%83K

-99.50%68K

15K

-56.05%13.58M

-16.40%13.58M

Net common stock issuance

--2.84M

--0

----

--0

-55.57%13.58M

----

Proceeds from stock option exercised by employees

----

4,050.00%83K

6,700.00%68K

--15K

----

-99.41%2K

-99.70%1K

--0

----

Cash from discontinued financing activities

Financing cash flow

--2.84M

-99.39%83K

-99.50%68K

--15K

--0

-56.05%13.58M

-16.40%13.58M

--0

----

Net cash flow

Beginning cash position

-55.48%10.53M

-7.66%23.66M

-69.24%3.83M

-77.49%3.03M

-74.98%5.59M

-7.66%23.66M

631.61%25.62M

-19.16%12.44M

-27.64%13.47M

49.18%22.36M

Current changes in cash

102.64%476K

-718.87%-13.15M

-41.76%6.48M

180.65%900K

70.59%-2.47M

-463.58%-18.06M

-107.27%-1.61M

9.41%11.12M

65.67%-1.12M

-338.99%-8.41M

Effect of exchange rate changes

-437.50%-43K

107.02%25K

132.65%228K

-223.53%-105K

81.13%-90K

87.10%-8K

-927.91%-356K

42.03%98K

269.57%85K

-537.61%-477K

End cash Position

96.03%10.97M

-55.48%10.53M

-69.24%3.83M

-77.49%3.03M

-74.98%5.59M

-7.66%23.66M

-19.16%12.44M

-27.64%13.47M

Free cash flow

9.63%-2.88M

14.37%-13M

35.55%-2.73M

6.17%-3.39M

10.62%-3.7M

0.53%-3.19M

-15.57%-15.18M

30.37%-4.23M

-11.02%-3.62M

-118.04%-4.13M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	2.89%-2.85M	12.39%-12.52M	35.95%-2.64M	0.06%-3.32M	4.28%-3.62M	4.02%-2.94M	-13.38%-14.29M	29.96%-4.13M	-5.37%-3.32M	-120.31%-3.79M
Net income from continuing operations	4.22%-3.61M	13.70%-14.65M	24.22%-3M	1.43%-4M	13.98%-3.89M	15.27%-3.77M	-71.58%-16.98M	-25.06%-3.95M	-40.51%-4.06M	-82.59%-4.52M
Operating gains losses	437.50%43K	-106.96%-25K	-93.22%-228K	223.53%105K	-82.00%90K	-87.10%8K	7,080.00%359K	-71.01%-118K	-269.57%-85K	558.72%500K
Depreciation and amortization	7.59%85K	30.24%323K	12.16%83K	17.14%82K	51.92%79K	51.92%79K	95.28%248K	80.49%74K	94.44%70K	92.59%52K
Change In working capital	-1.03%384K	144.39%523K	129.97%193K	-43.01%163K	11.95%-221K	-52.86%388K	106.78%214K	76.73%-644K	182.90%286K	-133.33%-251K
-Change in receivables	16.92%-54K	-106.61%-25K	-95.76%5K	183.33%10K	-90.46%25K	-750.00%-65K	204.42%378K	131.98%118K	-271.43%-12K	67.95%262K
-Change in inventory	330.99%164K	164.52%582K	333.33%371K	323.40%105K	154.13%177K	80.76%-71K	-1.23%-902K	12.15%-159K	84.79%-47K	-23.86%-327K
-Change in prepaid assets	-86.10%52K	-52.76%496K	125.04%161K	-177.83%-316K	-50.45%277K	-48.63%374K	151.72%1.05M	64.20%-643K	409.92%406K	9,216.67%559K
-Change in payables and accrued expense	637.93%156K	-26.95%-212K	-659.82%-627K	242.39%477K	-112.36%-33K	86.26%-29K	-170.76%-167K	166.67%112K	-1,057.14%-335K	92.09%267K
-Change in other current assets	56.25%75K	-25.71%182K	-21.95%64K	-17.65%56K	-78.79%14K	65.52%48K	140.36%245K	-29.31%82K	109.16%68K	375.00%66K
-Change in other current liabilities	-106.87%-9K	-28.21%-500K	242.21%219K	-182.04%-169K	36.83%-681K	-79.40%131K	-178.63%-390K	73.45%-154K	-74.09%206K	-245.68%-1.08M
Cash from discontinued investing activities
Operating cash flow	2.89%-2.85M	12.39%-12.52M	35.95%-2.64M	0.06%-3.32M	4.28%-3.62M	4.02%-2.94M	-13.38%-14.29M	29.96%-4.13M	-5.37%-3.32M	-120.31%-3.79M
Investing cash flow
Cash flow from continuing investing activities	103.25%491K	19.98%-713K	440.27%9.06M	90.74%4.2M	124.86%1.15M	-10,400.00%-15.12M	-123.50%-891K	1,036.31%1.68M	2,139.81%2.2M	-878.01%-4.63M
Net PPE purchase and sale	88.80%-28K	46.13%-480K	19.00%-81K	74.16%-77K	79.37%-72K	-73.61%-250K	-67.17%-891K	43.82%-100K	-175.93%-298K	-96.07%-349K
Net investment purchase and sale	103.56%529K	---529K	397.75%8.84M	71.09%4.28M	128.57%1.22M	---14.87M	--0	502.03%1.78M	--2.5M	-1,349.83%-4.28M
Net other investing changes	---10K	--296K	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	103.25%491K	19.98%-713K	440.27%9.06M	90.74%4.2M	124.86%1.15M	-10,400.00%-15.12M	-123.50%-891K	1,036.31%1.68M	2,139.81%2.2M	-878.01%-4.63M
Financing cash flow
Cash flow from continuing financing activities	2.84M	-99.39%83K	-99.50%68K	15K	0	0	-56.05%13.58M	-16.40%13.58M	0
Net common stock issuance	--2.84M	--0	----	----	----	--0	-55.57%13.58M	----	----	----
Proceeds from stock option exercised by employees	----	4,050.00%83K	6,700.00%68K	--15K	----	----	-99.41%2K	-99.70%1K	--0	----
Cash from discontinued financing activities
Financing cash flow	--2.84M	-99.39%83K	-99.50%68K	--15K	--0	--0	-56.05%13.58M	-16.40%13.58M	--0	----
Net cash flow
Beginning cash position	-55.48%10.53M	-7.66%23.66M	-69.24%3.83M	-77.49%3.03M	-74.98%5.59M	-7.66%23.66M	631.61%25.62M	-19.16%12.44M	-27.64%13.47M	49.18%22.36M
Current changes in cash	102.64%476K	-718.87%-13.15M	-41.76%6.48M	180.65%900K	70.59%-2.47M	-463.58%-18.06M	-107.27%-1.61M	9.41%11.12M	65.67%-1.12M	-338.99%-8.41M
Effect of exchange rate changes	-437.50%-43K	107.02%25K	132.65%228K	-223.53%-105K	81.13%-90K	87.10%-8K	-927.91%-356K	42.03%98K	269.57%85K	-537.61%-477K
End cash Position	96.03%10.97M	-55.48%10.53M	-55.48%10.53M	-69.24%3.83M	-77.49%3.03M	-74.98%5.59M	-7.66%23.66M	-7.66%23.66M	-19.16%12.44M	-27.64%13.47M
Free cash flow	9.63%-2.88M	14.37%-13M	35.55%-2.73M	6.17%-3.39M	10.62%-3.7M	0.53%-3.19M	-15.57%-15.18M	30.37%-4.23M	-11.02%-3.62M	-118.04%-4.13M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall